Skip to main content
SpringerLink
Log in

Absence of mutations in the AKT1 oncogene in glioblastomas and medulloblastomas

  • Correspondence
  • Published:
Acta Neuropathologica Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Broderick DK, Di C, Parrett TJ, Samuels YR, Cummins JM, McLendon RE, Fults DW, Velculescu VE, Bigner DD, Yan H (2004) Mutations of PIK3CA in anaplastic oligodendrogliomas, high-grade astrocytomas, and medulloblastomas. Cancer Res 64:5048–5050

    Article  PubMed  CAS  Google Scholar 

  2. Carpten JD, Faber AL, Horn C, Donoho GP, Briggs SL, Robbins CM, Hostetter G, Boguslawski S, Moses TY, Savage S, Uhlik M, Lin A, Du J, Qian YW, Zeckner DJ, Tucker-Kellogg G, Touchman J, Patel K, Mousses S, Bittner M, Schevitz R, Lai MH, Blanchard KL, Thomas JE (2007) A transforming mutation in the pleckstrin homology domain of AKT1 in cancer. Nature 448:439–444

    Article  PubMed  CAS  Google Scholar 

  3. Ermoian RP, Furniss CS, Lamborn KR, Basila D, Berger MS, Gottschalk AR, Nicholas MK, Stokoe D, Haas-Kogan DA (2002) Dysregulation of PTEN and protein kinase B is associated with glioma histology and patient survival. Clin Cancer Res 8:1100–1106

    PubMed  CAS  Google Scholar 

  4. Grasbon-Frodl EM, Kreth FW, Ruiter M, Schnell O, Bise K, Felsberg J, Reifenberger G, Tonn JC, Kretzschmar HA (2007) Intratumoral homogeneity of MGMT promoter hypermethylation as demonstrated in serial stereotactic specimens from anaplastic astrocytomas and glioblastomas. Int J Cancer 121:2458–2464

    Article  PubMed  CAS  Google Scholar 

  5. Hartmann W, Digon-Söntgerath B, Koch A, Waha A, Endl E, Dani I, Denkhaus D, Goodyer CG, Sörensen N, Wiestler OD, Pietsch T (2006) Phosphatidylinositol 3′-kinase/AKT signaling is activated in medulloblastoma cell proliferation and is associated with reduced expression of PTEN. Clin Cancer Res 12:3019–3027

    Article  PubMed  CAS  Google Scholar 

  6. Herms J, Neidt I, Luscher B, Sommer A, Schurmann P, Schroder T, Bergmann M, Wilken B, Probst-Cousin S, Hernaiz-Driever P, Behnke J, Hanefeld F, Pietsch T, Kretzschmar HA (2000) C-MYC expression in medulloblastoma and its prognostic value. Int J Cancer 89:395–402

    Article  PubMed  CAS  Google Scholar 

  7. Holland EC, Celestino J, Dai C, Schaefer L, Sawaya RE, Fuller GN (2000) Combined activation of Ras and Akt in neural progenitors induces glioblastoma formation in mice. Nat Genet 25:55–57

    Article  PubMed  CAS  Google Scholar 

  8. Kita D, Yonekawa Y, Weller M, Ohgaki H (2007) PI3KCA alterations in primary (de novo) and secondary glioblastomas. Acta Neuropathol 113:295–302

    Article  PubMed  CAS  Google Scholar 

  9. Knobbe CB, Reifenberger G (2003) Genetic alterations and abberant expression of genes related to the phosphatidy-inositol-3′-kinase/protein kinase B (Akt) signal transduction pathway in glioblastomas. Brain Pathol 13:507–518

    Article  PubMed  CAS  Google Scholar 

  10. Louis D, Ohgaki H, Wiestler OD, Cavenee W (2007) WHO classification of tumours of the central nervous system. IARC Press, Lyon

    Google Scholar 

  11. Osaki M, Oshimura M, Ito H (2004) PI3K-Akt pathway: its functions and alterations in human cancer. Apoptosis 9:667–676

    Article  PubMed  CAS  Google Scholar 

  12. Pelloski CE, Lin E, Zhang L, Yung WK, Colman H, Liu JL, Woo SY, Heimberger AB, Suki D, Prados M, Chang S, Barker FG III, Fuller GN, Aldape KD (2006) Prognostic associations of activated mitogen-activated protein kinase and Akt pathways in glioblastoma. Clin Cancer Res 12:3935–3941

    Article  PubMed  CAS  Google Scholar 

  13. Rao G, Pedone CA, Valle LD, Reiss K, Holland EC, Fults DW (2004) Sonic hedgehog and insulin-like growth factor signaling synergize to induce medulloblastoma formation from nestin-expressing neural progenitors in mice. Oncogene 23:6156–6162

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

The authors wish to thank Dr. F.-W. Kreth and Dr. J.-C. Tonn for making tumor samples available. U. Schüller and E. Grasbon-Frodl are supported by the Friedrich-Baur-Stiftung.

Author information

Authors and Affiliations

  1. Center of Neuropathology and Prion Research, Ludwig-Maximilians-University, Feodor-Lynen-Strasse 23, 81377, Munich, Germany

    Ulrich Schüller, Michael Ruiter, Jochen Herms, Hans A. Kretzschmar & Eva Grasbon-Frodl

Authors
  1. Ulrich Schüller
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Michael Ruiter
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Jochen Herms
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Hans A. Kretzschmar
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Eva Grasbon-Frodl
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ulrich Schüller.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Schüller, U., Ruiter, M., Herms, J. et al. Absence of mutations in the AKT1 oncogene in glioblastomas and medulloblastomas. Acta Neuropathol 115, 367–368 (2008). https://doi.org/10.1007/s00401-007-0334-2

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00401-007-0334-2

Keywords

Search

Navigation